Blog

Jan 22, 2024

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

Posted by in category: biotech/medical

A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.

Leave a reply